| [1] |
WHO Guidelines Approved by the Guidelines Review Committee.WHO recommendations for prevention and treatment of preeclampsia and eclampsia[R]. Geneva: World Health Organization, 2011.
|
| [2] |
American College of Obstetricians and GynecoIogists, Task Force on Hypertension in Pregnancy.Hypertension in pregnancy.Report of the American College of Obstetricians and Gynecologists′Task Force on hypertension in pregnancy[J]. Obstet Gynecol, 2013, 122(5): 1122-1131.
|
| [3] |
Sibai BM, Mirro R, Chesney CM, et al. Lose-dose aspirin in pregnancy[J]. Obstet gynecol, 1989, 74(4): 551-557.
|
| [4] |
Beaufils M, Uzan S, Donsimoni R, et al. Prevention of preeclampsia by early antiplatelet therapy[J]. Lancet，1985, 1(8433): 840-842.
|
| [5] |
Schiff E, Peleg E, Goldenberg M, et al. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies[J]. N Engl J Med, 1989, 321(3): 351-356.
|
| [6] |
Duley L, Henderson-Smart DJ, Meher S, et al. Antiplatelet agents for preventing preeclampsia and its complications[J]. Cochrane Database Syst Rev, 2007, 18(2): CD004659.
|
| [7] |
Askie LM, Duley L, Henderson-Smart DJ. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data[J]. Lancet, 2007, 369(9575): 1791-1998.
|
| [8] |
Villa PM, Kajantie E, Raeikkoenen K, et al. Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebocontrolled PREDO Trial and a meta-analysis of randomised trials[J]. BJOG, 2013, 120(1): 64-74.
|
| [9] |
徐婷婷，邓春艳，周凡，等. 低剂量阿司匹林对子痫前期高危人群预防效果的系统评价研究[J/CD]. 中华妇幼临床医学杂志电子版，2014, 10(5):21-28.
|
| [10] |
姚硕，吴焕，余艳红. 妊娠早中期服用阿司匹林对子痫前期高危人群预防作用的系统性评价[J]. 南方医科大学学报，2015, 35(6): 868-873.
|
| [11] |
Sibai BM, Caritis SN, Thom E, et al. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units[J]. N Engl J Med，1993, 329(17): 1213-1218.
|
| [12] |
Ebrashy A, Ibrahim M, Marzook A, et al.Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial[J]. Croat Med J, 2005, 46(5): 826-831.
|
| [13] |
Ayala DE, Ucieda R, Hermida RC. Chronotherapy with low-dose aspirin for prevention of complications in pregnancy[J]. Chronobiol Int, 2013, 30(1-2): 260-279.
|
| [14] |
Yu CK, Papageorghiou AT, Parra M, et al. Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks′ gestation[J]. Ultrasound Obstet Gynecol, 2003, 22(3): 233-239.
|
| [15] |
Rotchell YE, Cruickshank JK, Gay MP, et al. Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomized trial for the prevention of pre-eclampsia and its complications[J]. BJOG，1998, 105(3): 286-292.
|
| [16] |
CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group[J]. Lancet, 1994, 343(8898): 619-629.
|
| [17] |
Caritis S, Sibai B, Hauth J, et al. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units[J]. N Engl J Med, 1998, 338(11): 701-705.
|
| [18] |
Henderson JT, Whitlock EP, O′Connor E, et al. Low-Dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia: A Systematic Evidence Review for the U．S. Preventive Services Task Force[J]. Ann Intern Med, 2014, 160(10): 695-703.
|
| [19] |
LeFevre ML, U.S. Preventive Services Task Force. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia：U.S. Preventive Services Task Force recommendation statement[J]．Ann Intern Med, 2014, 161(11): 819-826.
|
| [20] |
Hermida RC, Ayala DE, Iglesias M, et al. Time-dependent effects of low-dose aspirin administration on blood pressure in pregnant women[J]. Hypertension，1997, 30 (3 Pt 2): 589-595.
|
| [21] |
Mcparland P, Pearce JM, Chamberlain GV. Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertension[J]. Lancet, 1990, 335(8705):1552-1555.
|
| [22] |
Subtil D, Goeusse P, Puech F, et al. Aspirin (100mg) used for prevention of pre-eclampsia in nulliparous women: the Essai Régional Aspirine Mère-Enfant study (Part 1)[J]. BJOG, 2003, 110(5): 475-484.
|
| [23] |
Kimmel CA, Wilson JG, Schumacher HJ. Studies on the metabolism and identification of the causative agent in aspirin teratogenesis[J]. Teratology, 1971, 4(1): 15-24.
|
| [24] |
Winship KA, Cahal DA, Weber JC，et al. Maternal drug histories and central nervous system Anomalies[J]. Arch Dis Child, 1984, 59(11):1052-1060.
|
| [25] |
Helms AK, Kittner SJ. Pregnancy and stroke[J]．CNS Spectr，2005, 10(7):580-587.
|
| [26] |
Visintin C, Mugglestone MA, Almerie MQ，et al.Management of hypertensive disorders during pregnancy：summary of NICE guidance[J]．BMJ, 2010, 341: c2207.
|
| [27] |
Sibai BM. Therapy: Low-dose aspirin to reduce the risk of pre-eclampsia ？[J]．Nat Rev Endocrinol, 2015, 11(1): 6-8.
|
| [28] |
Hauth JC, Goldenberg RL, Parker CR Jr, et al.Low-dose aspirin therapy to prevent preeclampsia[J]. Am J Obstet Gynecol, 1993, 168(4): 1083-1091.
|
| [29] |
Committee Opinion No. 638: First-trimester risk assessment for early-onset preeclampsia[J]. Obstet Gynecol, 2015, 126(3): e25-e27.
|